NeuroBo Pharmaceuticals Inc (NRBO)
4.20
+0.09
(+2.19%)
USD |
NASDAQ |
May 15, 15:26
NeuroBo Pharmaceuticals 1 Year Total Returns (Daily): -10.64% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 14, 2024 | -10.64% |
May 13, 2024 | -12.38% |
May 10, 2024 | -17.49% |
May 09, 2024 | -16.81% |
May 08, 2024 | -20.75% |
May 07, 2024 | -17.53% |
May 06, 2024 | -18.38% |
May 03, 2024 | -21.25% |
May 02, 2024 | -25.14% |
May 01, 2024 | -32.85% |
April 30, 2024 | -36.52% |
April 29, 2024 | -36.91% |
April 26, 2024 | -42.44% |
April 25, 2024 | -43.25% |
April 24, 2024 | -43.73% |
April 23, 2024 | -44.57% |
April 22, 2024 | -42.73% |
April 19, 2024 | -39.82% |
April 18, 2024 | -43.86% |
April 17, 2024 | -47.89% |
April 16, 2024 | -41.78% |
April 15, 2024 | -39.55% |
April 12, 2024 | -33.24% |
April 11, 2024 | -33.67% |
April 10, 2024 | -35.08% |
Date | Value |
---|---|
April 09, 2024 | -37.41% |
April 08, 2024 | -29.61% |
April 05, 2024 | -32.64% |
April 04, 2024 | -31.18% |
April 03, 2024 | -32.47% |
April 02, 2024 | -30.84% |
April 01, 2024 | -28.55% |
March 28, 2024 | -27.99% |
March 27, 2024 | -19.03% |
March 26, 2024 | -17.31% |
March 25, 2024 | -15.67% |
March 22, 2024 | -17.40% |
March 21, 2024 | -16.50% |
March 20, 2024 | -16.86% |
March 19, 2024 | -25.54% |
March 18, 2024 | -21.38% |
March 15, 2024 | -14.23% |
March 14, 2024 | -21.01% |
March 13, 2024 | -24.49% |
March 12, 2024 | -15.84% |
March 11, 2024 | -11.52% |
March 08, 2024 | -16.25% |
March 07, 2024 | -12.50% |
March 06, 2024 | -12.31% |
March 05, 2024 | 2.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.49%
Minimum
Sep 13 2023
22.05%
Maximum
Feb 26 2024
-68.82%
Average
-73.49%
Median
Dec 07 2021
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 76.86% |
SIGA Technologies Inc | 53.42% |
Vanda Pharmaceuticals Inc | -18.31% |
Tenon Medical Inc | -94.46% |
NovaBay Pharmaceuticals Inc | -91.36% |